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PARTIAL PORTACAVAL SHUNT: NARROW DIAMETER
H-GRAFT
ABSTRACT
Adam, R., Diamond, T. and Bismuth, H. (1992) Partial portacaval shunt: Renaissance of
an old concept. Surgery, 111,610-616.
Background. Partial diversion of the portal system aims to redeuce portal pressure
sufficiently to prevent variceal hemorrhage but still maintain adwquate hepatic portal
flow.
Methods. Partial portacaval shunts were performed in 25 patients with cirrhosis with
portal hypertension and esophageal varices, either as a primary procedure (n 16) or for
failure of endoscopic sclerotherapy (n= 9), with ringed polytetrafluoroethylene pros-
theses (8, 10, or 12 rnrn).
Results. All patients have now been followed up for at least 1 year. The operative
mortality rate (2 months) was 4%. In 24 patients who survived beyond the initial
perioperative period, there was no recurrence of variceal bleeding. Cumulative shunt
patency (up to 4 years) is 96%. Acute encephalopathy was detected in two patients (8%),
but no patients had signs of chronic encephalopathy. Intraoperative pressure measure-
ments revealed a signficant correlation between decreasing diameter of the graft and the
percentage reduction of the portacavai pressure gradient. Selective angiography, per-
formed 1 year after surgery, revealed that hepatopetal flow was maintained in 70% of
patients with a 10 Iron shunt.
Conclusions. It is possible to achieve a partial portacaval shunt, related to the diameter of
the prosthesis, that preserves hepatopetai flow in the majority ofpatients and is associated
with a very low incidence of shunt thrombosis. This effectively prevents recurrent variceal
bleeding and significant postoperative encephalopathy. The performance of subsequent
orthotopic liver transplantation is not compromised. The technique is recommended,
either as a primary procedure or when sclerotherapy has failed, in patients with good liver
function who are unlikely to require early liver transplantation (grade A and some grade
B cirrhosis). (SURGERY 1992; 111:610-6.)
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PAPER DISCUSSION
This important paper by Bismuth’s group, who intro-
duced the concept of partial diversion of the portal
system in 1967, provides further compelling support
for the efficacy of small diameter interposition ringed
polytetrafluoroethylene (PTFE) prosthetic portacaval
shunts in patients with variceal haemorrhage. Opera-
tive mortality was very low (4%), shunt patency up to
4 years was 96%, there was no recurrence of variceal
haemorrhage and no patients developed chronic en-
cephalopathy. It is to be noted, however, that only 33%
ofthese patients had alcoholic cirrhosis, that 68% were
Child-Pugh grade A, 32% were grade B and none were
grade C.
The results should be compared with those of Sarfeh
et al., who pioneered the use of small diameter ringed
PTFE shunts in 1983. In a systematic appraisal of
diameters of PTFE interposition prostheses (8 to
16mm) they found that optimal results in terms of
maintained mesenteric venous pressure, prograde
portal venous perfusion of the liver and incidence
of postoperative encephalopathy were obtained with
8mm diameter grafts. No patients with 16 to 20mm
diameter grafts, and only 1 of 12 with 12 to 14mm
diameter grafts retained prograde portal flow and the
overall incidence of encephalopathy in these groups
was 39%. With 10mm diameter shunts prograde
portal flow was maintained in 46% and the incidence
of encephalopathy was 19%. With 8mm diameter
grafts prograde flow was present in over 80%.of pati-
ents (9 of 11) and the incidence of encephalopathy
was 9%. Late patency of grafts, up to 5 years, was 97%
and no patients with 8 or 10mm grafts rebled from
varices.
In the present series the majority (19 of 25) patients
had 10mm diameter grafts, 4 patients had 12mm
diameter grafts and 8mm grafts were used in only
2 pati- ents. Portal perfusion data were available only
in 10 of the 19 patients with 10mm grafts and in these
prograde perfusion was demonstrable in 70%, com-
pared with 46% in Sarfeh’s study. If the findings in
these 10 patients are representative of the whole sub-
group of 19 patients with 10mm grafts, and if Sarfeh’s
findings with 12mm diameter grafts can be extrapo-
lated to the 4 patients with 12mm grafts in this series it
is possible that 17 of the entire group of 25 patients
(68%) lost prograde portal perfusion. This must be
viewed in the context of the zero incidence of chronic
encephalopathy in the entire series. This suggests that
there is no straight correlation between the occurrence
of encephalopathy and maintenance of prograde por-
tal venous perfusion.
This is supported by the results of a recent study by
Johansen2 comparing total (2.5 cm) with partial (1.2 to
1.5cm) side-to-side portacaval shunts. The encepha-
lopathy incidence in partial (small diameter) shunts
was 8% versus 56% with total portocaval shunts.
There was also a significant late survival advantage in
patients with partial shunts (13% vs 39% late deaths).
Angiographic and Duplex sonographic studies re-
vealed that all patients in both groups had reversal of
flow in the distal limb of the portal vein, indicating
uniform loss of first-pass hepatic portal perfusion. This
suggests that besides hepatic portal perfusion, other
factors must be operative in the genesis of hepatic and
neurological dysfunction after shunting.
This is also relevant to the situation after distal
splenorenal shunts (DSRS). Our3 and other studies
have documented the low incidence ofencephalopathy
after DSRS. This occurs despite the apparent loss of
prograde portal venous perfusion with time in up to
50% of patients with alcoholic cirrhosis after DSRS
reported by Warren et al4. In our study of 141 patients
with DSRS3’5 the frequency of failure to demonstrate
prograde portal venous perfusion by DTPA hepatic
flow scintigraphy only occurred in alcoholic cirrhotics,
but was less (23%) than reported by Warren, and there
was no difference in the incidence of encephalopathy
between alcoholic cirrhotics and non-alcoholic
cirrhotics. The incidence of encephalopathy was zero
in non-cirrhotic patients after DSRS (mainly schisto-
somiasis and portal vein thrombosis).
The continuing debate about the apparent loss of
selectivity after DSRS is therefore of questionable rel-
evance in the light of the above, and the clinical2 and
experimental
6 evidence for the importance ofpreserva-
tion of physiologic mesenteric venous pressures in the
prevention of postshunt hepatic functional deteriora-
tion and encephalopathy. It is suggested that this may
well be largely responsible for the excellent results in
this regard following DSRS and partial portacavalHPB INTERNATIONAL 59
decompression with small diameter PTFE interposi-
tion grafts.
The confirmation of Sarfeh’s experience of durable
patency with the use of small diameter ringed PTFE
interposition prosthetic grafts appears to have allayed
residual reservations about this procedure. Further
experience over more extended periods will be required
to establish whether it will truly match the excellent
long term patency rate and functional results of the
DSRS. In my view it has established a place in the
operative therapeutic armamentarium for portal hy-
pertension, especially for patients where a DSRS is
impossible, for example patients who have undergone
a,previous ill advised splenectomy. The technical sim-
plicity and safety of this procedure are also appealing
in the less common context of emergency shunting,
although it is doubtful whether it will have a major
impact on the much greater operative mortality experi-
enced with all forms of emergency operative interven-
tion in Childs grade C patients.
2. Johansen, K. (1992) Prospective comparison of partial versus
total portal decompression for bleeding esophageal varices. Surg.
Gynecol. Obstel., 175, 528-34.
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ences. Am. J. Surg., 16t), 67-72.
4. Warren, W. D., Millikan, W. J. and Henderson, J. M. et al. (1984)
Selective variceal decompression after splenectomy or splenic vein
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Surg., 199, 694-72.
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GASTRIC VARICES: FIRST YOU HAVE TO SEE THEM
ABSTRACT
Sarin, S.K., Iahoti, D., Saxena, S.P., Murthy, N.S., and Makwana, U.K. (1992)
Prevalence, Classification and Natural History of Gastric Varices: A longtermfollow-up
study in 568 portal hypertension patients. Hepatology, 16, 1343-1349.
To determine the prevalence and natural history of gastric varices, we prospectively
studied 568 patients (393 bleeders and 175 nonbleeders) with portal hypertension
(cirrhosis in 301 patients, noncirrhotic portal fibrosis in 115 patients, extrahepatic portal
vein obstruction in 117 patients and hepatic venous outflow obstruction in 35 patients).
Primary (present at initial examination) gastric varices were seen in 114 (20%) patients;
more were present in bleeders than in nonbleeders (27% vs. 4%, respectively; p < 0.001).
Secondary (occurring after obliteration of esophageal varices) gastric varices developed
in 33 (9%) patients during follow-up of 24.6__+ 5.3 too. Gastric varices (compared with
esophageal varices) bled in significantly fewer patients (25% vs. 64%, respectively).
Gastric varices had a lower bleeding risk factor than did esophageal varices (2.0_ 0.5 vs.
4.3 +__ 0.4, respectively) but bled more severely (4.8 _+ 0.6 vs. 2.9 ___
0.3 transfusion units per
patient, respectively). Once a varix bled, mortality was more likely (45%) in gastric varix